2025
SJR Q4
JCR Q4 · 0,4
9 matched articles
SCIE
Journal detail
Yakugaku Zasshi
- Publisher
- Pharmaceutical Society of Japan
- Country
- Japan · Asiatic Region
- Type
- journal
- ISSN
-
0031690313475231
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,136
- Quartile Q4
- H-Index 49
- Cites/doc 0,34
- Docs (3y) 461
- Cites (3y) 161
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,4
- 5Y JIF 0,3
- JCI 0,06
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmaceutical Science Q4
- Pharmacology Q4
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q4 | Q4 | 0,136 | 0,4 | 0,3 | 0,06 | Q4 | 49 |
| 2024 | Q3 | Q4 | 0,153 | 0,2 | 0,3 | 0,06 | Q4 | 48 |
| 2023 | Q3 | Q4 | 0,165 | 0,3 | 0,3 | 0,07 | Q4 | 48 |
| 2022 | Q3 | Q4 | 0,153 | 0,3 | 0,3 | 0,06 | Q4 | 48 |
| 2021 | Q3 | Q4 | 0,148 | 0,3 | 0,4 | 0,06 | Q4 | 48 |
| 2020 | Q3 | Q4 | 0,141 | 0,3 | 0,3 | 0,07 | Q4 | 48 |
| 2019 | Q3 | Q4 | 0,155 | 0,3 | 0,3 | 0,08 | Q4 | 48 |
| 2018 | — | Q4 | — | 0,3 | 0,2 | 0,08 | Q4 | — |
| 2017 | Q3 | Q4 | 0,154 | 0,3 | 0,3 | 0,09 | Q4 | 48 |
| 2016 | Q3 | Q4 | 0,168 | 0,3 | 0,3 | — | — | 48 |
| 2015 | Q4 | Q4 | 0,112 | 0,2 | 0,3 | — | — | 48 |
| 2014 | Q3 | Q4 | 0,189 | 0,3 | 0,4 | — | — | 48 |
| 2013 | Q3 | Q4 | 0,199 | 0,3 | 0,4 | — | — | 48 |
| 2012 | Q3 | Q4 | 0,215 | 0,5 | 0,4 | — | — | 48 |
| 2011 | Q3 | Q4 | 0,22 | 0,4 | 0,5 | — | — | 48 |
| 2010 | Q2 | Q4 | 0,228 | 0,4 | 0,5 | — | — | 48 |
| 2009 | — | Q4 | — | 0,4 | 0,4 | — | — | — |
| 2008 | — | Q4 | — | 0,4 | 0,4 | — | — | — |
| 2007 | — | Q4 | — | 0,3 | 0,4 | — | — | — |
| 2006 | — | Q4 | — | 0,2 | — | — | — | — |
| 2005 | — | Q4 | — | 0,3 | — | — | — | — |
| 2004 | — | Q4 | — | 0,3 | — | — | — | — |
| 2003 | — | Q4 | — | 0,3 | — | — | — | — |
| 2002 | — | Q4 | — | 0,4 | — | — | — | — |
| 2001 | — | Q4 | — | 0,4 | — | — | — | — |
| 2000 | — | Q4 | — | 0,3 | — | — | — | — |
| 1999 | — | Q4 | — | 0,2 | — | — | — | — |
| 1998 | — | Q4 | — | 0,3 | — | — | — | — |
| 1997 | — | Q4 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 348/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 345/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 344/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 274/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 276/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 273/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 268/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 264/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 258/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 253/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 253/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 251/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 244/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 235/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 239/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 232/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 223/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 208/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 198/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 196/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 186/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 181/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 179/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 172/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 172/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 172/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 168/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 166/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 149/157 |